WallStreetZenWallStreetZen

NASDAQ: BBIO
Bridgebio Pharma Inc Stock Ownership - Who owns Bridgebio Pharma?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Bridgebio Pharma Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Thomas TrimarchiPresident and CFO2025-08-2142,237$49.49
$2.09MSell
Neil KumarChief Executive Officer2025-08-20428$49.25
$21.08kSell
Neil KumarChief Executive Officer2025-08-2025,728$48.81
$1.26MSell
Thomas TrimarchiPresident and CFO2025-08-181,973$50.94
$100.51kSell
Thomas TrimarchiPresident and CFO2025-08-1815,380$50.14
$771.21kSell
Neil KumarChief Executive Officer2025-08-1632,855$51.32
$1.69MSell
Maricel ApuliChief Accounting Officer2025-08-164,781$51.32
$245.36kSell
Thomas TrimarchiPresident and CFO2025-08-1621,317$51.32
$1.09MSell
Charles J. HomcyDirector2025-08-1150,000$48.00
$2.40MSell
Charles J. HomcyDirector2025-08-08191,662$45.87
$8.79MSell

1 of 9

BBIO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BBIO insiders and whales buy or sell their stock.

BBIO Shareholders

What type of owners hold Bridgebio Pharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Kkr Group Partnership LP19.30%36,900,661$1.81BInsider
Viking Global Performance LLC13.93%26,620,991$1.31BInsider
Viking Global Investors LP9.71%18,555,375$910.70MInsider
Viking Global Investors LP9.71%18,555,375$910.70MInstitution
Vanguard Group Inc8.62%16,484,985$809.08MInstitution
Blackrock Inc7.46%14,259,479$699.86MInstitution
Kohlberg Kravis Roberts Co LP6.94%13,260,971$650.85MInstitution
Kkr Genetic Disorder LP6.94%13,260,971$650.85MInsider
Janus Henderson Group PLC4.85%9,276,532$455.29MInstitution
Farallon Capital Management LLC4.13%7,900,000$387.73MInstitution

1 of 3

BBIO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BBIO63.75%36.25%Net SellingNet Selling
MDGL26.14%73.86%Net BuyingNet Buying
VRNA11.01%51.87%Net SellingNet Selling
TECH97.62%2.38%Net BuyingNet Buying
HALO77.20%22.80%Net SellingNet Selling
View Top Biotech Stocks

Bridgebio Pharma Stock Ownership FAQ

Who owns Bridgebio Pharma?

Bridgebio Pharma (NASDAQ: BBIO) is owned by 98.75% institutional shareholders, 56.14% Bridgebio Pharma insiders, and 0.00% retail investors. Kkr Group Partnership LP is the largest individual Bridgebio Pharma shareholder, owning 36.90M shares representing 19.30% of the company. Kkr Group Partnership LP's Bridgebio Pharma shares are currently valued at $1.81B.

If you're new to stock investing, here's how to buy Bridgebio Pharma stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.